Novavax, Inc. (NASDAQ:NVAX) People
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| David Mott Other companies: Mersana Therapeutics Inc (Director · Since at least Jun 27, 2017); Ardelyx, Inc. (Chairman · Since at least Jun 18, 2014); Enliven Therapeutics, Inc. (Director · Mar 11, 2020 – Jun 2, 2022 · Past); Nightstar Therapeutics PLC (Director · Jan 1, 2019 – Jun 7, 2019 · Past); Adaptimmune Therapeutics PLC (Director · Jan 1, 2016 – Jul 1, 2024 · Past); Epizyme Inc (Director · May 30, 2013 – Aug 12, 2022 · Past); Omthera Pharmaceuticals Inc (Director · Apr 11, 2013 – Jul 18, 2013 · Past); Tesaro Inc (Director · Jun 27, 2012 – Jan 22, 2019 · Past); Medimmune Inc (Vice Chair. of the Board, CEO, Director · Feb 23, 2006 – Jun 18, 2007 · Past) | Director · Since at least Jun 16, 2020 |
| Gail K. Boudreaux Other companies: Target Corporation (Director · Since at least Sep 23, 2021); Elevance Health, Inc. (President and CEO · Since at least Nov 20, 2017); Zimmer Biomet Holdings, Inc. (Director · Dec 10, 2012 – Mar 31, 2021 · Past); Xcel Energy Inc. (Director · Mar 1, 2012 – Dec 28, 2017 · Past); UnitedHealth Group Incorporated (EVP & CEO, UnitedHealthcare · May 5, 2008 – Sep 23, 2014 · Past); Genzyme Corp (Director · May 25, 2006 – Apr 4, 2011 · Past) | Director · Jun 17, 2015 – Mar 16, 2017 · Past |
| Richard Rodgers Other companies: Opus Genetics, Inc. (Director · Since at least Dec 2, 2014); Ardelyx, Inc. (Director · Since at least Jun 18, 2014); Sagimet Biosciences Inc. - Series A (Director · Jul 13, 2023 – Jul 18, 2023 · Past); Tesaro Inc (Executive VP & CFO · Jun 27, 2012 – Mar 6, 2013 · Past); Abraxis BioScience Inc (Senior Vice President and CFO · Jul 9, 2009 – Jul 13, 2009 · Past); Mgi Pharma Inc (Sr. VP and Controller · Jul 15, 2006 – Jan 28, 2008 · Past) | Director · Since at least Oct 29, 2022 |
| Charles Newton Other companies: Keros Therapeutics, Inc. (Director · Since at least Feb 26, 2026); Coherus Oncology, Inc. (Director · Since at least May 4, 2022); Lyell Immunopharma, Inc. (Chief Financial Officer · Since at least Jun 16, 2021); 2Seventy Bio Inc (Director · Mar 20, 2024 – May 13, 2025 · Past) | Director · Since at least Apr 25, 2025 |
| Gregory F Covino Other companies: Tesaro Inc (SVP, CAO, PAO · Aug 13, 2018 – Jan 22, 2019 · Past); Biogen Inc. (VP, Chief Accounting Officer · May 1, 2012 – Mar 1, 2018 · Past); Hubbell Inc (Vice President, Controller · Dec 4, 2006 – Dec 6, 2007 · Past) | EVP, Chief Financial Officer · Nov 16, 2020 – Nov 16, 2020 · Past |
| Margaret G McGlynn Other companies: Amicus Therapeutics Inc (Director · Since at least Oct 28, 2009); Vertex Pharmaceuticals Incorporated (Director · May 12, 2011 – May 1, 2023 · Past); Air Products and Chemicals, Inc. (Director · Dec 31, 2005 – Sep 30, 2020 · Past) | Director · Since at least Dec 7, 2020 |
| Mark Casey Other companies: Mallinckrodt Inc (EVP & Chief Legal Officer · Feb 1, 2018 – Jun 16, 2022 · Past); Aceragen Inc. (Senior VP & General Counsel · Jun 29, 2015 – Jan 3, 2018 · Past); Hologic Inc (SVP, CAO, GC & Secretary · Jan 11, 2008 – Nov 18, 2014 · Past) | Executive Vice President, Chief Legal Officer · Since at least Dec 11, 2023 |
| James Patrick Kelly Other companies: Supernus Pharmaceuticals, Inc. (Executive Vice-President & CFO · Oct 12, 2020 – Feb 19, 2021 · Past); Vanda Pharmaceuticals Inc. (EVP & Chief Financial Officer · Jan 2, 2020 – Mar 2, 2020 · Past) | EVP, CFO and Treasurer · Since at least Aug 16, 2021 |
| Rachel King Other companies: Fulcrum Therapeutics, Inc. (Board Member · Since at least Nov 12, 2024); Crescent Biopharma, Inc. (Director · Jan 7, 2016 – May 1, 2024 · Past) | Director · Since at least Oct 31, 2018 |
| Richard H. Douglas Other companies: Aldeyra Therapeutics, Inc. (Director · Since at least Jun 10, 2026); MaxCyte, Inc. (Director · Since at least Dec 22, 2024) | Director · Since at least Jun 20, 2026 |
| Ian Watkins Other companies: Mallinckrodt Inc (See Remarks · Nov 11, 2020 – Jun 16, 2022 · Past) | Executive Vice President, Chief Human Resources Officer · Since at least Nov 5, 2026 |
| John C. Jacobs Other companies: Harmony Biosciences Holdings, Inc. (PRESIDENT, CEO, Director · Aug 18, 2020 – Aug 15, 2022 · Past) | President and Chief Executive Officer · Since at least Jan 23, 2023 |
| John Shiver Other companies: Icosavax Inc (Director · Jan 3, 2022 – Jun 6, 2023 · Past) | Director · Since at least Mar 10, 2025 |
| Dennis W Genge | VP, Treasurer,CFO · Feb 17, 2006 – Feb 17, 2006 · Past |
| Elaine O’Hara | Executive Vice President, Chief Strategy Officer · Since at least Nov 5, 2026 |
| Gregg Alton | Director · Since at least Jun 20, 2026 |
| Jim Kelly | Executive Vice President, Chief Financial Officer and Treasurer · Since at least Jun 1, 2026 |
| Jim Robinson | VP, Technical & Quality Ops. · Aug 2, 2007 – Mar 5, 2009 · Past |
| John A Herrmann III | EVP, Chief Legal Officer · Jul 31, 2015 – Dec 14, 2023 · Past |
| John O Marsh Jr | Director · Feb 17, 2006 – Mar 6, 2014 · Past |
| Raymond Joseph Hage | Sr. VP. Commercial Operations · May 4, 2005 – Jul 1, 2009 · Past |
| Rick Crowley | Executive Vice President, Chief Operations Officer · Since at least Nov 4, 2026 |
| Rick Rodgers | Director · Since at least Jun 23, 2026 |
| Robert Walker | EVP, R&D · Since at least Mar 30, 2026 |
| Silvia Taylor | Executive Vice President, Chief Corporate Affairs Officer and Head of Novavax Sweden · Since at least Nov 5, 2026 |
| Timothy Jon Hahn | SVP, Manufacturing · Jun 10, 2013 – Mar 5, 2015 · Past |
| Troy Morgan | Senior Vice President, Deputy General Counsel & Chief Compliance Officer · Since at least Nov 5, 2026 |